Friday, July 10, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “qing” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 138
Total indexed 20,548
Sponsors 1,771

Quick answer

Showing 138 pipeline programs matching "qing" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

138 results for “qing” Back to intelligence hub

Search results

Page 6 of 6
  1. Salkera Emollient Foam

    Chongqing Precision Biotech Co., Ltd

    Keratosis Pilaris

    approved small molecule terminated

    1 trial
  2. Topiramate

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Alcohol Dependence

    approved small molecule active

    1 trial
  3. risperidone

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Neuroleptic-Induced Tardive Dyskinesia

    approved small molecule completed

    1 trial
  4. Aescin in Horse Chestnut

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Anorectal Disorder

    small molecule active

    1 trial
  5. Biobanking with genetic analysis

    Chongqing Precision Biotech Co., Ltd

    Chronic Inflammatory Disease

    gene therapy active

    1 trial
  6. CMV-VST

    Chongqing Precision Biotech Co., Ltd

    Cytomegalovirus Viremia

    mab active

    1 trial
  7. Fei Re Qing Granules

    The First People's Hospital of Lianyungang

    Severe Pneumonia Caused by Multidrug-resistant Gram-negative Bacterial Infection

    small molecule active

    1 trial
  8. Lang Qingata

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    NASH

    small molecule active

    1 trial
  9. Phase 1 Wonderlab Product

    Chongqing Precision Biotech Co., Ltd

    Diabetes

    other completed

    1 trial
  10. QiMeiYan Probiotics

    Chongqing Precision Biotech Co., Ltd

    IBS - Irritable Bowel Syndrome

    other completed

    1 trial
  11. Qingre Huashi Granules combined the modified dual therapy

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    small molecule active

    1 trial
  12. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight and Obesity

    other completed

    1 trial
  13. Study product A (Wonderlab wonder4shape)

    Chongqing Precision Biotech Co., Ltd

    Overweight

    other completed

    1 trial
  14. Triferdine

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    Pregnancy Related

    other completed

    1 trial
  15. WonderLab Collagen Tripeptide Drink

    Chongqing Precision Biotech Co., Ltd

    Skin Laxity

    other completed

    1 trial
  16. Wonderlab Kids instant probiotics

    Chongqing Precision Biotech Co., Ltd

    Immunity

    other completed

    1 trial
  17. Wonderlab Nicotinamide Drink

    Chongqing Precision Biotech Co., Ltd

    Skin Darken

    other completed

    1 trial
  18. placebo

    Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co.,

    PCOS- Polycystic Ovary Syndrome

    other active

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.